ALK and anaplastic large cell lymphoma: Despite the fact that the ECHELON‐2 study was not designed to evaluate the role of upfront consolidation with ASCT, numerical PFS estimates favored the use of consolidative SCT in patients with ALK‐negative ALCL and with non‐ALCL who achieved a CR at the end of induction after frontline BV‐CHP.23